Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry

Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry

Background Dual antiplatelet therapy (DAPT) reduces ischemic events but increases bleeding risk, especially in patients with high bleeding risk (HBR). This study aimed to compare outcomes of abbreviated versus standard DAPT strategies in patients with HBR with acute coronary syndrome undergoing perc...

Full description

Bibliographic Details
Main Authors: Anton Håkansson, Sasha Koul, Elmir Omerovic, Jonas Andersson, Stefan James, Stefan Agewall, Arash Mokhtari, Jesper van Der Pals, Axel Wester, Karolina Szummer, Tomas Jernberg, David Erlinge, Moman A. Mohammad
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
dual antiplatelet therapy
high bleeding risk
percutaneous coronary intervention
SWEDEHEART
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.034709

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.124.034709

Similar Items